Effect of proton pump inhibitors on gastric juice volume, gastric pH and gastric intramucosal pH in critically ill patients: A randomized, double-blind, placebo-controlled study

Clinical Drug Investigation

Volumn 28, Issue 12, 2008, Pages 777-782

  Gursoy, Olcay ^a   Memiş, Dilek ^a   Sut, Necdet ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Esomeprazole, pharmacodynamics; Intensive care units; Omeprazole, pharmacodynamics; Pantoprazole, pharmacodynamics; Proton pump inhibitors, pharmacodynamics; Rabeprazole, pharmacodynamics

Indexed keywords

ERBOLIN; ESOMEPRAZOLE; OMEPRAZOLE; PANTO; PANTOPRAZOLE; PLACEBO; RABEPRAZOLE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PH MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; STOMACH CONTENT; STOMACH JUICE; STOMACH MUCOSA; STOMACH PH;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; CRITICAL ILLNESS; DOUBLE-BLIND METHOD; FEMALE; GASTRIC ACIDITY DETERMINATION; GASTRIC JUICE; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS;

EID: 55849087629     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/0044011-200828120-00005     Document Type: Article

References (21)

1. Stedman CAM, Barclay ML. Comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther 2000; 14: 963-78
2. Doglio GR, Pusajo JF, Egurrola MA, et al. Gastric mucosal pH as a prognostic index of mortality in critically ill patients. Crit Care Med 1991; 19: 1037-41
3. 2 and its influence on the intramural pH in gastric mucosa. J Surg Res 1982; 33: 39-48
4. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-29
5. Sachs G, Shin JM, Briving C, et al. The pharmacology of the gastric acid pump: the H+,K+ ATPase. Ann Rev Pharmacol Toxicol 1995; 35: 277-305
6. Huber R, Kohl B, Sachs G, et al. The continuing development of proton pump inhibitors with particular reference to pantoprazole. Aliment Pharmacol Ther 1995; 9: 363-78
7. 2 receptor antagonists: a crossover endoscopic and intragastric pH study in the dog. J Pharmacol Exp Ther 1987; 243: 1179-84
8. Konturek SJ, Brzozowski T, Radecki T. Protective action of omeprazole, a benzimidazole derivative, on gastric mucosal damage by aspirin and ethanol in rats. Digestion 1983; 27: 159-64
9. Mattsson H. Protective effects of omeprazole in the gastric mucosa. Scand J Gastroenterol 1986; 21 Suppl. 118: 72-4
10. Daneshmend TK, Stein AG, Bhaskar NK, et al. Abolition by omeprazole of aspirin induced gastric mucosal injury in man. Gut 1990; 31: 514-7
11. 2 receptor antagonists. Biochem Pharmacol 1993; 45: 2389-96
12. Lapenna D, Gioia S, Ciofani G, et al. Anti-oxidant properties of omeprazole. FEBS Lett 1996; 382: 189-92
13. Lichtenberger LM, Ulloa C, Romero JJ, et al. Nonsteroidal antiinflammatory drug and phospholipid prodrug: combination therapy with antisecretory agents in rats. Gastroenterology 1996; 111: 990-5
14. Brett S. The use of proton pump inhibitors for gastric acid supression in critical illness. Crit Care 2005; 9: 45-50
15. Calvet X, Baigorri F, Duarte M, et al. Effect of sucralfate on gastric intramucosal pH in critically ill patients. Intensive Care Med 1997; 23: 738-42
16. Calvet X, Baigorri F, Duarte M, et al. Effect of ranitidine on gastric intramucosal pH in critically ill patients. Intensive Care Med 1998; 24: 12-7
17. Stannard A, Hutchinson A, Morris DL, et al. Gastric exocrine failure in critically ill patients: incidence and associated features. BMJ 1988; 296: 155-6
18. Higgins D, Mythen MG, Webb AR. Low intramucosal pH is associated with failure to acidify the gastric lumen in response to pentagastrin. Intensive Care Med 1994; 20: 105-8
19. Hunt RH. Acid, bacteria and the mucosal barrier: aspiration or translocation as the cause of pneumonia? Eur J Gastroenterol Hepatol 1992; 4: 881-4
20. Hellström PM, Vitols S. All proton pump inhibitors are equally efficacious in standard dosages. Lakartidningen 2003; 100: 2212-6
21. Welage LS, Berardi RR. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases. J Am Pharm Assoc (Wash) 2000; 40: 52-62